Gumusay, Ö. Et Al. 2021. Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC). CANCER RESEARCH , no.4 .

Gumusay, Ö., Magbanua, M. J. M., Majure, M. C., Deal, T., Renslo, J. R., Wabl, C. A., ... Melisko, M. E.(2021). Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC). CANCER RESEARCH , no.4.

Gumusay, ÖZGE Et Al. "Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)," CANCER RESEARCH , no.4, 2021

Gumusay, ÖZGE Et Al. "Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)." CANCER RESEARCH , no.4, 2021

Gumusay, Ö. Et Al. (2021) . "Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)." CANCER RESEARCH , no.4.

@article{article, author={ÖZGE GÜMÜŞAY Et Al. }, title={Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC)}, journal={CANCER RESEARCH}, year=2021}